Fierce Drug Delivery: Eli Lilly Latches onto Bend Research's Spray-Dried Dispersion Technology

February 15, 2012
Fierce Drug Delivery

Bend Research is becoming the belle of the drug delivery ball. The company disclosed this week that it has expanded a deal with struggling pharmaceutical giant Eli Lilly (LLY) to include a license of its proprietary spray-dried dispersion technology, as well as access to Bend's other drug delivery technologies. Bend says it has previously supported some of Lilly's preclinical and clinical development programs with various formulation, development, analytical, engineering and manufacturing services. Neither side disclosed financial or project details.